Association Between Insurance Status at Diagnosis and Overall Survival in Chronic Myeloid Leukemia: A Population-Based Study

BACKGROUND: Chronic myeloid leukemia (CML) can be treated effectively with tyrosine kinase inhibitor (TKI) therapy directed at BCR-ABL, but access to care, medication cost, and adherence may be barriers to treatment. We sought to determine whether insurance status at diagnosis influences CML patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Perry, Ashley M., Brunner, Andrew M., Zou, Tao, McGregor, Kristin L., Amrein, Philip C., Hobbs, Gabriela S., Ballen, Karen K., Neuberg, Donna S., Fathi, Amir T.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5474167/
https://ncbi.nlm.nih.gov/pubmed/28464280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30639
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars